Publications by authors named "Luca Pompili"

Claim this Profile
C
Cancer Organoids as reliable disease models to drive clinical development of novel therapies.
Giovanni Blandino, Ronit Satchi-Fainaro, Ingeborg Tinhofer, Giovanni Tonon, Sarah C Heilshorn, Luca Pompili

J Exp Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Roberto Dinami, Luca Pompili, Eleonora Petti, Manuela Porru, Carmen D'Angelo

EMBO Mol Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Ilaria Romito, Manuela Porru, Maria Rita Braghini, Luca Pompili, Nadia Panera

J Exp Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Ilaria Romito, Manuela Porru, Maria Rita Braghini, Luca Pompili, Nadia Panera

J Exp Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Effective Anticancer G-Quadruplex-Targeting Chemotypes through the Exploration of a High Diversity Library of Natural Compounds.
Chiara Platella, Francesca Ghirga, Pasquale Zizza, Luca Pompili, Simona Marzano

Pharmaceutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the KRAS oncogene: Synthesis, physicochemical and biological evaluation of novel G-Quadruplex DNA binders.
Federica D'Aria, Vincenzo Maria D'Amore, Francesco Saverio Di Leva, Jussara Amato, Marco Caterino, Luca Pompili

Eur J Pharm Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA2 Deletion Induces Alternative Lengthening of Telomeres in Telomerase Positive Colon Cancer Cells.
Luca Pompili, Carmen Maresca, Angela Dello Stritto, Annamaria Biroccio, Erica Salvati

Genes (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyads of G-Quadruplex Ligands Triggering DNA Damage Response and Tumour Cell Growth Inhibition at Subnanomolar Concentration.
Filippo Doria, Erica Salvati, Luca Pompili, Valentina Pirota, Carmen D'Angelo

Chemistry· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xenograft as In Vivo Experimental Model.
Manuela Porru, Luca Pompili, Carla Caruso, Carlo Leonetti

Methods Mol Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.
Manuela Porru, Luca Pompili, Carla Caruso, Annamaria Biroccio, Carlo Leonetti

J Exp Clin Cancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Luca Pompili, Carlo Leonetti, Annamaria Biroccio, Erica Salvati

J Exp Clin Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived xenografts: a relevant preclinical model for drug development.
Luca Pompili, Manuela Porru, Carla Caruso, Annamaria Biroccio, Carlo Leonetti

J Exp Clin Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis